Having trouble accessing articles? Reset your cache.

Pazopanib: Additional Phase II data

Researchers at the Mayo Clinic reported additional data from an open-label Phase II trial in 37 evaluable patients with metastatic, rapidly progressive, radioiodine-refractory

Read the full 236 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE